CLOV

CLOV Stock-Based Compensation

$72.38MTTM · USD

Period ending:

CLOV FY Stock-Based CompUSD
CLOV FY Stock-Based Comp2018-12-31: $3.68M2019-12-31: $3.30M2020-12-31: $0.002021-12-31: $163.72M2022-12-31: $164.31M2023-12-31: $140.93M2024-12-31: $114.33M2025-12-31: $103.66M$164.31M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CLOV stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Clover Health Investments Corp Cla Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
103,657,000
114,331,000
140,931,000
164,305,000
163,723,000
0
3,301,000
3,680,000

Compare stock-based compensation

All CLOV financial metrics · CLOV stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.